The Australasian Cognitive Neurology Association (ACNA) provides guidelines for the consideration of the use of the recently TGA approved biomarker blood test for ptau217 in Alzheimer disease. More details can be found here: ACNA ptau217 Blood Test Guidelines PDF v1.0.
These guidelines are a living document and updates will be posted as necessary.